Health insurance revenue is expected to grow at an annualised 10.1% over the five years through 2025-26 to $3.3 billion. Revenue growth has been largely premium price-driven, with insurers elevating their coverage cost offerings to meet rising healthcare expenditure expectations. Health insurance companies have reported an increasing volume of claims paid as the population aged 50 and over has risen. This expanding demand for coverage has been coupled with inflationary pressures on the healthcare services themselves, highlighting how equipment, availability and labour shortages are putting pressure on the sector. Recent inflationary trends have allowed insurers to lift their premiums to maintain viability. This trend has supported profitability, as the industry's predominantly not-for-profit business model previously kept margins slim. A decent percentage of New Zealanders view health insurance as a necessary cost, giving insurers more power to raise costs without experiencing significant membership churn. Health consciousness among the population has also intensified, supporting health insurance coverage. A rise in employer-subsidised memberships has contributed to increasing coverage rates. Private health insurance has become more significant to the overall health system, as highlighted by an increasing share of private health expenditure in total health expenditure. The public health system provides essential services to all citizens, residents and certain visa holders. However, it doesn’t generally cover non-urgent treatment and elective surgery. Private health insurance bridges the gap by allowing policyholders to access private hospitals and shorter waiting periods for non-urgent procedures. New Zealand's ageing and growing population is extending these public wait times, incentivising private membership. The number of health insurance policies offered by employers is expected to spike in 2025-26, providing an anticipated 9.1% boost to revenue for the year. Health insurance revenue is forecast to rise at an annualised 7.4% through the end of 2030-31, to $4.7 billion, as expensive premium pricing continues to support industry revenue growth. Total private health insurance membership numbers will grow over that period, especially among young professionals and families, bolstering industry revenue. As the population aged 50 and over grows, claims expenses are set to rise and the cost of healthcare services is forecast to swell. These factors will continue to push insurers to lift premiums, bolstering revenue and the industry's position as a key part of the healthcare system.

Market Size statistics on the Health Insurance industry in New Zealand

In 2019, Oceania Healthcare Holding Limited in New Zealand had the most shares in Oceania Healthcare, owning over *** million shares. Contrastingly, PT (Booster Investments) Nominees Limited owned just under * million shares. Oceania Healthcare provides retirement villages in New Zealand and was founded in 2008. Since its founding it has expanded significantly and grown as a company.

Downstream markets continue to pay premium prices for specialised medical, surgical and scientific equipment. Manufacturers’ robust negotiating leverage enables them to generate expansive profitability and pass on hiked input costs to their downstream markets. Despite this, profitability has plunged as purchase costs and wages mount. Population growth, particularly in the demographic aged 50 and over, has contributed to rising demand for industry equipment. Strong demand for ventilators during the pandemic catalysed revenue growth in the three years through 2021-22. This trend has also allowed New Zealand to make a mark as a renowned medical equipment manufacturer, lifting exports' revenue share. However, as the pandemic’s influence has waned thanks to better disease management controls and vaccination programs, revenue has receded from its record high. Overall, industry revenue is anticipated to have dipped at an annualised 0.6% over the five years through 2024-25, to $1.9 billion. This trend includes an expected uptick of 0.3% in 2024-25 as public health expenditure climbs. Manufacturers engage in fierce international trade, which means fluctuations in the New Zealand dollar’s value affect the industry's overall performance. Imports have encroached on the market, with low-cost, standardised equipment markets ripe for competition. A growing need for highly skilled employees has made it challenging for manufacturers to ramp up production to capitalise on demand. This, coupled with the climbing labour intensity, has escalated wages. Revenue growth is projected to expand over the next few years as the ever-growing population of people aged 50 and older heightens demand for medical equipment. The number of older people seeking care services at home will climb, boosting demand for home care equipment. Manufacturers will capitalise on this trend through aggressive R&D efforts and new product ranges. Governments worldwide are poised to ramp up healthcare expenditure, facilitating manufacturers' expansion. However, manufacturers in countries with lower operating costs will become capable of producing increasingly sophisticated products, intensifying competition from imports. That's why the industry profitability will narrow but remain high. Overall, industry revenue is forecast to rise at an annualised 2.5% over the five years through 2029-30, to $2.2 billion.

The Hospitals industry has been expanding, resulting from the growing and ageing population putting more pressure on the healthcare system. Growth in New Zealand's overall population, particularly in the population aged 70 and older, has accelerated some illnesses that typically occur as people age. This has boosted the demand for medical services, applying more pressure on public hospitals, which dominate the Hospitals industry via their provision of all acute, emergency and intensive care. New Zealand's hospitals are facing substantial workforce shortages which has added extra pressure on hospitals and associated profit margins. Overall revenue is expected to climb at an annual rate of 2.2% to $25.5 billion through the end of 2025-26. This includes a 2.7% hike in 2025-26. New Zealand operates a dual public-private health system. While its hospital system is primarily publicly funded and managed, private hospitals are playing a growing role, especially in the provision of elective surgeries, as waitlists in the public system continue to grow. Increased reliance on private hospitals, resulting from a climb in private health insurance membership and expanded demand for healthcare services, is gradually changing the industry's operating environment. It has also encouraged the entry of new private hospital providers and the establishment of new surgical day facilities. Wide-ranging health care reforms introduced in 2022 are also impacting the industry's operating backdrop as the government seeks to address various challenges and create a more cohesive and nationally coordinated hospital system. The Hospitals industry will continue to benefit from a growing and ageing population in the coming years. This trend will strengthen demand for healthcare services, especially as the government seeks to improve access and health outcomes for Māori and Pasifika communities through its Healthy Futures Act. However, public hospitals will continue to face ongoing challenges associated with ageing infrastructure despite government capital investment as part of its national 10-year Health Infrastructure Plan. This in turn, may provide opportunities for private hospital providers to help alleviate capital and capacity constraints within the wider Hospitals industry. Government case-mix funding is set to continuously support the Hospitals industry. Similarly, expected growth in private health insurance membership and the number of births is also likely to stimulate this industry’s growth. Revenue is forecast to climb at an annualised 1.9% to $28.1 billion through the end of 2030-31.

Ryman Healthcare reported NZD1.79B in Market Capitalization this October of 2025, considering the latest stock price and the number of outstanding shares.Data for Ryman Healthcare | RYM - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last October in 2025.

Fisher Paykel Healthcare reported NZD22.13B in Market Capitalization this October of 2025, considering the latest stock price and the number of outstanding shares.Data for Fisher Paykel Healthcare | FPH - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last October in 2025.

The market is expected to reach USD 16.0 million by 2025 and is likely to grow at an estimated 4.6% CAGR from 2025 to 2035.

Attributes	Details
Estimated Value (2035)	USD 16.0 million
Value-based CAGR (2025 to 2035)	4.6%

Market Concentration

Vendor Tier	Tier 1
Key Vendors	Indivior, Alkermes, Camurus
Market Share (%)	60%
Description	Global leaders offering MAT solutions, including long-acting buprenorphine and extended-release naltrexone.

Vendor Tier	Tier 2
Key Vendors	Teva Pharmaceuticals, Aspen Pharma
Market Share (%)	25%
Description	Regional manufacturers providing affordable MAT options and generic formulations.

Vendor Tier	Tier 3
Key Vendors	Harm Reduction Australia, Telehealth NZ
Market Share (%)	15%
Description	Non-profits and digital health platforms delivering accessible and innovative care solutions.

Vital Healthcare Property reported NZD1.53B in Market Capitalization this October of 2025, considering the latest stock price and the number of outstanding shares.Data for Vital Healthcare Property | VHP - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last October in 2025.

The total market size of the information technology sector in New Zealand was estimated to reach over *********** U.S. dollars in 2022. According to the source, the leading subsectors included consumer technology, gaming, artificial intelligence, and digital health.

Vital Healthcare Property stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.

The size of the New Zealand Insulin Drugs and Devices market was valued at USD XXX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 1.10% during the forecast period.Insulin drugs and devices are key management tools of diabetes mellitus, a chronic condition resulting from the hyper-glycaemic state. Insulin drugs imitate the physiological insulin action and are used to control blood glucose levels. These drugs come in multiple forms of delivery, such as insulin pens, vials, and prefilled syringes.Insulin delivery devices are designed to administer insulin accurately and conveniently. For example, an insulin pen is a portable device that allows for precise dosing and easy self-injection. An insulin pump is a more advanced device that delivers continuous or bolus doses of insulin, giving the individual more precise control over their blood sugar.The rise of Type 2 diabetes with risk factors such as obesity and sedentary lifestyle influences the New Zealand market of insulin drugs and devices. In addition to the above, an aging population further fuels the growth in diabetes care.Pharmac is New Zealand's system for the healthcare sector, through which the government decides what medicines are available and at what prices to the patient. Funding through pharmac influences the choice of the patients or more significantly on what the treatment choice is as decided by the healthcare provider.Diabetes continues to emerge as a serious concern to health in New Zealand; the market for drugs and devices used for diabetes in terms of insulin will, therefore, tend to increase with improvements in technology and rising awareness of the growing diabetic population. Key drivers for this market are: Increasing Geriatric Population and Changing Dietary Habits, High Prevalence of Irritable bowel syndrome with constipation (IBS-C) and Opioid-induced constipation (OIC) and Chronic Constipation; Development of Latest Drugs and Treatment Procedures. Potential restraints include: Increasing Dependence on Majority of Over-the-Counter (OTC) Drugs, Lack of Awareness and Reluctance Among Patients due to Adverse Effects of Opioid-Induced Constipation (OIC) Drugs. Notable trends are: Rising diabetes prevalence.

The New Zealand Payments Market Report is Segmented by Mode of Payment (Point of Sale, Online), Interaction Channel (Point-Of-Sale, E-commerce/M-commerce), Transaction Type (P2P, C2B, B2B, Remittances and Cross-Border), End-User Industry (Retail, Entertainment and Digital Content, Healthcare, Hospitality & Travel, and More). The Market Forecasts are Provided in Terms of Value (USD).

Market Size statistics on the Medical, Surgical and Scientific Equipment Manufacturing industry in New Zealand

The New Zealand ICT market, valued at approximately $X million in 2025 (assuming a logical extrapolation based on the provided CAGR and market size), is projected to experience robust growth at a compound annual growth rate (CAGR) of 7.20% from 2025 to 2033. This expansion is fueled by several key drivers. The increasing adoption of cloud computing, big data analytics, and artificial intelligence across diverse sectors—particularly BFSI, IT and Telecom, and the burgeoning e-commerce landscape—is significantly boosting demand for ICT solutions. Government initiatives promoting digital transformation and infrastructure development further contribute to market growth. Furthermore, the rising need for cybersecurity solutions amidst increasing cyber threats acts as a major catalyst. The market is segmented by type (hardware, software, IT services, telecommunication services), enterprise size (SMEs and large enterprises), and industry vertical, reflecting the varied applications of ICT across New Zealand's economy. Leading players such as IBM, Amazon, Microsoft, Google, and local telecom providers dominate the market, leveraging their established infrastructure and expertise. However, the market's growth is not without challenges. Potential restraints include the relatively small size of the New Zealand market, potentially limiting the scale of operations for some ICT providers. Fluctuations in the global economy and technological advancements requiring continuous investment in infrastructure and skills development also pose challenges. Despite these limitations, the ongoing digitalization across all sectors and the government's emphasis on technological advancement ensure a positive outlook for the New Zealand ICT market. The expanding adoption of 5G technology and the growth of IoT are expected to further fuel market expansion in the coming years, particularly within the telecommunication services segment. The competitive landscape is dynamic, with both international and local players vying for market share, creating a robust and innovative ecosystem. Recent developments include: April 2022: IBM NZ, MATRIXX Software, and Vodafone NZ declared about extending their partnership to offer enterprise-wide digital commerce to all of its post-pay, pre-pay, wholesale, and IoT customers. By replacing and updating Vodafone's charging system as part of this most recent partnership extension, IBM Consulting and MATRIXX would provide consumers with a new digital experience., January 2022: Spark, one of the leading telecommunication companies in New Zealand, unveiled the completion of its strategic buy-out of telecommunication infrastructure contractor Connect 8 Ltd. The agreement is a part of Spark's efforts to boost the rollout of 5G. The financial information about the purchase was kept private.. Key drivers for this market are: Robust Growth of Technology Export, Government Investments in Digital Healthcare. Potential restraints include: Robust Growth of Technology Export, Government Investments in Digital Healthcare. Notable trends are: Robust Growth of Technology Export.

The wireless caregiver pager market, currently valued at $675 million in 2025, is projected to experience steady growth, driven by a rising elderly population globally and increasing demand for remote patient monitoring solutions. The market's Compound Annual Growth Rate (CAGR) of 1.7% reflects a consistent, albeit moderate, expansion over the forecast period (2025-2033). Key drivers include the escalating need for independent living solutions among seniors, the increasing adoption of telehealth technologies in healthcare settings, and the convenience and affordability of wireless pager systems compared to traditional communication methods. While technological advancements and a broader range of features are contributing to market growth, potential restraints include concerns regarding the reliability of wireless signals in certain areas, potential integration challenges with existing healthcare IT infrastructures, and the need for user-friendly interfaces and training programs for both caregivers and patients. Companies like Silent Communications NZ Ltd, Calltou Co., Ltd, and Smart Caregiver are leading players, focusing on innovation and catering to evolving market demands. The market segmentation (while unspecified in the provided data) likely includes variations in pager features (e.g., range, alert types, battery life), price points, and target user groups (e.g., home care, assisted living facilities, hospitals). Further analysis indicates that regional market variations are likely significant, reflecting diverse healthcare infrastructure development and economic factors. While precise regional data is unavailable, it’s reasonable to expect higher market penetration in developed economies with robust healthcare systems and a larger aging population compared to developing nations. The historical period (2019-2024) likely showed similar growth patterns, influenced by pre-existing trends, suggesting that the projected CAGR is a conservative estimate based on current market dynamics. Future growth will heavily depend on successful integration with emerging technologies like IoT (Internet of Things) devices and smart home solutions, as well as regulatory support and initiatives promoting home-based healthcare. The consistent growth, despite a moderate CAGR, highlights the enduring relevance and potential of wireless caregiver pagers within the evolving landscape of senior care and remote healthcare monitoring.

Market Size statistics on the Other Health Services industry in New Zealand

The global green lipped mussel extract market, valued at $551 million in 2025, is projected to experience robust growth, driven by increasing consumer awareness of its health benefits and expanding applications in both human and animal nutraceuticals. The market's Compound Annual Growth Rate (CAGR) of 6.2% from 2025 to 2033 indicates a significant expansion opportunity. Key drivers include the rising prevalence of joint pain and inflammation, leading to increased demand for natural anti-inflammatory supplements. Furthermore, the growing pet care industry fuels the demand for animal nutraceuticals, contributing to market expansion. The market segmentation reveals a significant portion allocated to human nutraceuticals, reflecting the considerable consumer interest in natural health solutions. While the "less than 200 mesh" segment likely dominates due to its suitability for various applications, the "above 200 mesh" segment offers growth potential as specialized applications emerge. Geographic distribution suggests North America and Europe currently hold larger market shares, driven by higher disposable incomes and awareness of health and wellness products. However, Asia-Pacific, particularly China and India, are poised for significant growth, given their expanding middle class and increasing adoption of functional foods and supplements. Market restraints could include price volatility associated with raw material sourcing and potential regulatory challenges related to supplement standardization. The competitive landscape includes established players such as Maclab Group, Enzaq, and Aroma NZ, indicating both consolidation and innovation within the industry. The forecast period (2025-2033) promises substantial growth, fueled by ongoing research into the bioactive compounds of green lipped mussel extract and the development of innovative product formulations. Companies are likely to focus on product diversification, expanding into new applications and geographical markets. Strategic partnerships and mergers and acquisitions could also play a crucial role in shaping the market's competitive dynamics. The continued emphasis on natural and sustainable sourcing will also become increasingly important, influencing consumer choices and the overall market trajectory. Addressing potential regulatory hurdles and maintaining consistent product quality will be vital for long-term success in this growing market. The market's success will largely depend on continued scientific validation of its efficacy and the effective communication of its benefits to both consumers and healthcare professionals.

The New Zealand Cybersecurity Market Report is Segmented by Offering (Solutions [Application Security, Cloud Security, and More], Services [Professional Services, and More]), Deployment Mode (Cloud, On-Premise), End-User Industry (BFSI, Healthcare, IT and Telecom, Industrial and Defense, Retail and E-Commerce, and More), End-User Enterprise Size (Large Enterprises, Smes). The Market Forecasts are Provided in Terms of Value (USD).

In 2024, the New Zealand medical instruments market increased by 10% to $386M, rising for the fourth consecutive year after two years of decline. Over the period under review, consumption saw strong growth. Medical instruments consumption peaked in 2024 and is likely to see gradual growth in the near future.